Index NDX, S&P 500
P/E 47.87
EPS (ttm) 10.82
Insider Own 1.03%
Shs Outstand 80.74M
Perf Week 5.37%
Market Cap 41.67B
Forward P/E 37.95
EPS next Y 13.65
Insider Trans -2.04%
Shs Float 79.59M
Perf Month 28.76%
Income 894.97M
PEG 3.60
EPS next Q 3.28
Inst Own 94.33%
Short Float 3.60%
Perf Quarter 16.55%
Sales 3.93B
P/S 10.60
EPS this Y 13.90%
Inst Trans 1.97%
Short Ratio 3.28
Perf Half Y 21.59%
Book/sh 17.93
P/B 28.89
EPS next Y 12.33%
ROA 27.26%
Short Interest 2.87M
Perf Year -0.58%
Cash/sh 2.04
P/C 254.11
EPS next 5Y 13.28%
ROE 59.33%
52W Range 356.14 - 547.22
Perf YTD 25.31%
Dividend Est. -
P/FCF 49.15
EPS past 5Y 16.90%
ROI 44.86%
52W High -5.32%
Beta 1.55
Dividend TTM -
Quick Ratio 0.76
Sales past 5Y 10.23%
Gross Margin 61.33%
52W Low 45.48%
ATR (14) 13.81
Dividend Ex-Date -
Current Ratio 1.10
EPS Y/Y TTM 4.66%
Oper. Margin 29.20%
RSI (14) 79.00
Volatility 1.77% 2.68%
Employees 11000
Debt/Eq 0.73
Sales Y/Y TTM 5.56%
Profit Margin 22.76%
Recom 1.92
Target Price 531.89
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q 5.57%
Payout 0.00%
Rel Volume 0.60
Prev Close 511.99
Sales Surprise 0.13%
EPS Surprise 3.93%
Sales Q/Q 3.56%
Earnings May 01 BMO
Avg Volume 873.68K
Price 518.10
SMA20 10.76%
SMA50 19.45%
SMA200 15.53%
Trades
Volume 524,926
Change 1.19%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-02-24 Initiated
Leerink Partners
Outperform
$500
Jul-25-24 Initiated
BTIG Research
Buy
$580
Jan-30-24 Downgrade
Piper Sandler
Overweight → Neutral
$525
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$602
Dec-04-23 Upgrade
Cleveland Research
Neutral → Buy
Aug-02-23 Downgrade
Atlantic Equities
Overweight → Neutral
$610
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Show Previous Ratings
May-15-25 08:06AM
May-14-25 09:40AM
May-13-25 02:30PM
May-08-25 09:08AM
May-02-25 02:00PM
03:05AM
Loading…
03:05AM
May-01-25 02:01PM
(Morningstar Research) +8.95%
10:35AM
09:49AM
09:30AM
07:40AM
06:37AM
(Associated Press Finance)
06:30AM
Apr-30-25 09:31AM
07:33AM
10:01AM
Loading…
Apr-29-25 10:01AM
09:45AM
09:15AM
08:10AM
Apr-28-25 09:50AM
Apr-24-25 08:01PM
10:01AM
Apr-22-25 11:25AM
Apr-21-25 08:34AM
Apr-13-25 08:49PM
Apr-10-25 05:47AM
Apr-09-25 09:45AM
Apr-07-25 08:14AM
Apr-04-25 12:10PM
09:25AM
08:50AM
Loading…
08:50AM
Apr-03-25 01:30PM
Apr-02-25 08:50AM
Mar-29-25 09:05AM
Mar-27-25 11:50PM
04:16PM
Mar-26-25 11:13AM
09:21AM
Mar-24-25 12:36PM
Mar-20-25 06:40AM
Mar-18-25 02:50PM
Mar-12-25 03:08PM
09:28AM
Mar-11-25 07:22PM
Mar-05-25 11:30AM
Feb-19-25 11:15AM
Feb-14-25 08:27AM
Feb-13-25 02:00PM
Feb-12-25 07:58AM
Feb-10-25 09:39AM
Feb-07-25 07:09AM
Feb-04-25 04:40PM
02:02AM
12:20AM
(Thomson Reuters StreetEvents)
Feb-03-25 07:33PM
(Morningstar Research) +11.13%
04:42PM
04:02PM
(Investor's Business Daily)
11:51AM
11:42AM
11:31AM
11:05AM
10:54AM
09:51AM
09:30AM
07:40AM
06:46AM
(Associated Press Finance)
06:30AM
Feb-01-25 07:07AM
Jan-29-25 04:22PM
Jan-16-25 04:15PM
Dec-26-24 09:45AM
Dec-20-24 04:02PM
Dec-19-24 10:09AM
Dec-13-24 08:45AM
Dec-09-24 06:58PM
07:30AM
Nov-27-24 09:00AM
Nov-21-24 07:30AM
Nov-07-24 08:44AM
Nov-06-24 04:11AM
Nov-05-24 09:53AM
Nov-01-24 01:24PM
03:05AM
03:01AM
(Thomson Reuters StreetEvents)
Oct-31-24 01:16PM
(Morningstar Research) -9.79%
01:15PM
09:30AM
07:40AM
06:41AM
(Associated Press Finance)
06:30AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-17-24 11:43AM
Oct-11-24 09:06AM
Oct-10-24 10:55AM
Oct-08-24 10:16AM
Oct-06-24 12:53PM
Sep-30-24 02:00PM
Sep-18-24 10:48PM
Sep-05-24 11:31AM
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
JUNIUS DANIEL M Director May 13 '25 Option Exercise 263.81 2,683 707,801 5,987 May 14 05:00 PM JUNIUS DANIEL M Director May 13 '25 Sale 506.41 2,683 1,358,697 3,304 May 14 05:00 PM JUNIUS DANIEL M Director May 13 '25 Proposed Sale 506.41 2,683 1,358,697 May 13 07:32 PM Vandebroek Sophie V. Director May 09 '25 Option Exercise 283.59 1,279 362,712 2,446 May 13 05:00 PM Vandebroek Sophie V. Director May 09 '25 Sale 491.34 1,279 628,425 1,167 May 13 05:00 PM Vandebroek Sophie V. Director May 09 '25 Proposed Sale 491.34 1,279 628,425 May 09 04:18 PM Vandebroek Sophie V. Director May 06 '25 Option Exercise 0.00 262 0 1,167 May 08 07:01 PM SZOSTAK M ANNE Director May 06 '25 Option Exercise 0.00 262 0 262 May 08 07:01 PM Kingsley Lawrence D Director May 06 '25 Option Exercise 0.00 346 0 9,229 May 08 07:01 PM JUNIUS DANIEL M Director May 06 '25 Option Exercise 0.00 262 0 3,304 May 08 07:01 PM ESSIG STUART Director May 06 '25 Option Exercise 0.00 262 0 2,236 May 08 07:00 PM COLLINS Asha Director May 02 '25 Proposed Sale 497.63 2,671 1,329,167 May 02 04:19 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 14 '25 Option Exercise 0.00 1,162 0 32,119 Feb 18 09:44 PM Smith Martin Alexander Executive Vice President Feb 14 '25 Option Exercise 0.00 1,231 0 1,766 Feb 18 09:43 PM Schreck Michael Executive Vice President Feb 14 '25 Option Exercise 0.00 1,459 0 2,397 Feb 18 09:43 PM MAZELSKY JONATHAN JAY President and CEO Feb 14 '25 Option Exercise 0.00 2,747 0 84,505 Feb 18 09:43 PM Lane Michael Executive Vice President Feb 14 '25 Option Exercise 0.00 885 0 7,375 Feb 18 09:43 PM Johnson Michael Perkins Executive Vice President Feb 14 '25 Option Exercise 0.00 355 0 585 Feb 18 09:43 PM Hunt Nimrata Executive Vice President Feb 14 '25 Option Exercise 0.00 872 0 12,595 Feb 18 09:43 PM FENNELL GEORGE Executive Vice President Feb 14 '25 Option Exercise 0.00 304 0 8,480 Feb 18 09:42 PM Erickson Michael G Executive Vice President Feb 14 '25 Option Exercise 0.00 557 0 21,393 Feb 18 09:42 PM Erickson Michael G Executive Vice President Feb 11 '25 Option Exercise 67.85 1,544 104,760 20,836 Feb 12 05:04 PM FENNELL GEORGE Executive Vice President Feb 10 '25 Option Exercise 79.54 9,986 794,286 18,162 Feb 11 05:00 PM FENNELL GEORGE Executive Vice President Feb 07 '25 Option Exercise 79.54 1,256 99,902 8,176 Feb 11 05:00 PM FENNELL GEORGE Executive Vice President Feb 10 '25 Sale 462.53 9,986 4,618,862 8,176 Feb 11 05:00 PM FENNELL GEORGE Officer Feb 10 '25 Proposed Sale 463.46 9,966 4,618,863 Feb 10 05:52 PM SZOSTAK M ANNE Director Feb 07 '25 Sale 465.94 3,000 1,397,835 3,061 Feb 10 05:03 PM Margaret Anne Szostak Director Feb 07 '25 Proposed Sale 460.56 3,000 1,381,680 Feb 07 04:08 PM Vandebroek Sophie V. Director Nov 27 '24 Sale 420.44 344 144,630 905 Nov 29 05:00 PM Vandebroek Sophie V. Director Nov 27 '24 Proposed Sale 420.44 344 144,630 Nov 27 04:36 PM SZOSTAK M ANNE Director Sep 06 '24 Sale 469.37 500 234,686 0 Sep 09 04:18 PM M. Anne Szostak Director Sep 06 '24 Proposed Sale 469.78 500 234,890 Sep 06 04:36 PM Schreck Michael Executive Vice President Sep 01 '24 Option Exercise 0.00 164 0 961 Sep 04 08:20 PM Smith Martin Alexander Executive Vice President Sep 01 '24 Option Exercise 0.00 18 0 515 Sep 04 08:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Aug 05 '24 Option Exercise 0.00 192 0 31,049 Aug 07 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 05 '24 Option Exercise 0.00 384 0 81,903 Aug 07 05:00 PM